Indoco gets USFDA popularity of Olanzapine Tablets

Indoco gets USFDA popularity of Olanzapine Tablets

by admin- Thursday, August 6th, 2020 04:04:02 PM

Indoco Remedies announced receipt of approval for its ANDA for Olanzapine Tablets USP 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20 mg. The products are therapeutically equivalent to the Reference Listed Drug ‘Zyprexa’ of Eli Lilly.

Olanzapine is indicated for the remedy of schizophrenia and bipolar disease. The drug will also be used in mixture with different medicinal drug to deal with depression and certain intellectual conditions.

The US market length of Olanzapine Tablets is USD sixty five million as in keeping with available IMS data.

News Updates